Literature DB >> 7528503

Quantitative RT-PCR assay detecting the transcriptional induction of vascular endothelial growth factor under hypoxia.

M Iizuka1, M Yamauchi, K Ando, N Hori, Y Furusawa, H Itsukaichi, K Fukutsu, H Moriya.   

Abstract

Quantitative reverse transcription-polymerase chain reaction (RT-PCR) assay was used to examine the induction of vascular endothelial growth factor (VEGF) transcript in human osteosarcoma cells, MG-63, under hypoxic culture condition. Using this assay system, the expression of VEGF mRNA was estimated eight-fold higher when cells were cultured under hypoxic condition. Transcription level of hypoxanthine phosphoribosyl transferase (HPRT) mRNA was also examined as an internal control. HPRT mRNA level under hypoxia was reduced to one fourteenth. Secretion of VEGF into the cell culture medium was implied by its stimulating activity on the growth of mouse vascular endothelial cultured cells in vitro.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7528503     DOI: 10.1006/bbrc.1994.2831

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Microvascular endothelial cells sustain preadipocyte viability under hypoxic conditions.

Authors:  Cynthia A Frye; Xuemei Wu; Charles W Patrick
Journal:  In Vitro Cell Dev Biol Anim       Date:  2005 May-Jun       Impact factor: 2.416

Review 2.  [Transmyocardial laser revascularization--an innovative pathophysiologic concept].

Authors:  C G Brilla; L Rybinski; D Gehrke; H Rupp
Journal:  Herz       Date:  1997-08       Impact factor: 1.443

Review 3.  Tumor angiogenesis: the pivotal role of vascular endothelial growth factor.

Authors:  D Marmé
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

4.  Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression.

Authors:  E Brogi; G Schatteman; T Wu; E A Kim; L Varticovski; B Keyt; J M Isner
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

5.  A novel hypoxia-dependent 2-nitroimidazole KIN-841 inhibits tumour-specific angiogenesis by blocking production of angiogenic factors.

Authors:  M Shimamura; H Nagasawa; H Ashino; Y Yamamoto; T Hazato; Y Uto; H Hori; S Inayama
Journal:  Br J Cancer       Date:  2003-01-27       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.